Indivior | L'Utile Operativo



Operating Profit Cambiamento Data
AstraZeneca USD 3.67B 1.64B 2025-03
Divis Laboratories Ltd 7.79B 1.35B 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
Glaxosmithkline GBP 702M 513M 2024-12
Halozyme Therapeutics USD 141.54M 33.97M 2025-03
Indivior 66M 226M 2025-03
J&J USD 13.63B 9.74B 2025-03
Kyowa Hakko Kirin JPY 7.43B 19.5B 2025-03
Merck USD 5.87B 1.57B 2025-03
Novartis USD 3.4B 193M 2024-12
Pfizer USD 3.67B 4.08B 2025-03
Sanofi EUR 861M 2.77B 2024-12
Supernus Pharmaceuticals USD 21.4M 19.44M 2024-12



Indivior L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.